XOMAP

Q: What is the price of XOMA (XOMAP) today?

The price of XOMA (XOMAP) today is R$ 143,11, with a variation of 13.56% compared to the last year. The price of XOMA (XOMAP) started the year trading around R$ 0,00 and today it is at R$ 143,11. Follow the real-time price chart, the historical price of XOMA (XOMAP), and stock data from Ibovespa and international markets.

Q: When does XOMA (XOMAP) pay dividends?

XOMA (XOMAP) distributed dividends in the last year,in the months of January, April, July e October totaling R$ 11,56. The Dividend Yield for the last 12 months is 6,34%.

Q: XOMA (XOMAP) is it worth it?

Currently, XOMA (XOMAP) is priced at R$ 143,11, with a P/E of -10,03%, representing a deviation of -11,90% from its historical average P/E. In the last year, the stock showed a variation of 13.56% in its price and distributed R$ 11,56 in dividends, resulting in a Dividend Yield of 6,34%. The total shareholder return was 13,56%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of XOMA (XOMAP)?

Investing in stocks of XOMA (XOMAP) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of XOMA (XOMAP) yield today?

The yield of XOMA (XOMAP) was 4,50% in the last month, 13,56% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 11,56 in dividends, um Dividend Yield de 6,34%.If you wanted to buy 100 stocks of XOMA (XOMAP) today, the total investment would be R$ 14.311,20, based on the current price of R$ 143,11.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 16.251,80In 5 years: R$ 14.311,20In 10 years: 14.311,20It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

XOMA Corporation

Price

US$ 26,70

variation (12m)

13,56%

p/l

-10,03

p/vp

3,54

DIVIDEND YIELD

6,34%

price XOMAP

BVMF

XOMAP

If you had invested

years ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of XOMAP

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

4,50%

3 months

5,59%

1 year

13,56%

2 years

33,39%

5 years

0,00%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

4,50%

3 months

5,43%

1 year

8,49%

2 years

22,04%

5 years

0,00%

10 years

0,00%

Indicators XOMAP

check out the fundamentals of XOMA shares

P/E

-10,03

Sector: -3,15 Industry: -3,15

P/SALES RATIO (PSR)

13,90

Sector: -4,36 Industry: -4,36

P/BV

3,54

Sector: 1,77 Industry: 1,77

DIVIDEND YIELD (DY)

6,34%

Sector: - Industry: -

ROA

-13,41%

Sector: -63,23% Industry: -63,23%

ROE

-35,33%

Sector: -69,95% Industry: -69,95%

ROIC

Sector: -2.093,52% Industry: -2.093,52%

NET MARGIN

-100,00%

Sector: -41,50% Industry: -41,50%

GROSS MARGIN

90,61%

Sector: 38,30% Industry: 38,30%

OPERATING MARGIN

-71,26%

Sector: -40,80% Industry: -40,80%

P/EBITDA

-19,79

Sector: -3,30 Industry: -3,30

P/EBIT

-19,51

Sector: -3,30 Industry: -3,30

P/ASSET

1,34

Sector: 1,31 Industry: 1,31

BVPS

7,20

Sector: 1,82 Industry: 1,82

EPS

-2,54

Sector: -2,18 Industry: -2,18

EQUITY / ASSETS

0,38

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

0,00%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

0,00%

Sector: - Industry: -

XOMAP indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
JNJ	16,71	5,43	32,50%	2,83%	US$ 426,17 B	27,75%
PFE	15,38	1,59	10,33%	6,87%	US$ 141,44 B	15,13%
ABBV	100,08	-2.728,87	-2.726,81%	3,04%	US$ 376,58 B	6,45%
NVO	15,01	9,45	62,99%	3,05%	US$ 245,59 B	34,74%
MRK	11,91	4,29	36,03%	3,81%	US$ 210,57 B	28,16%
AZN	27,19	5,65	20,79%	2,53%	US$ 253,27 B	16,23%
BMY	18,63	5,49	29,44%	5,22%	US$ 95,93 B	10,71%
GILD	20,41	7,31	35,82%	2,71%	US$ 143,24 B	24,71%
ZTS	25,77	13,71	53,20%	1,26%	US$ 68,23 B	28,00%
HALO	15,49	27,25	175,93%	0,00%	US$ 9,07 B	48,21%
REGN	13,35	2,01	15,06%	0,46%	US$ 60,20 B	31,83%
AMGN	29,23	20,54	70,29%	2,47%	US$ 152,60 B	14,67%
VRTX	28,08	5,93	21,11%	0,00%	US$ 101,80 B	31,22%
ADMA	19,62	10,21	52,03%	0,00%	US$ 4,07 B	43,51%
MCK	23,18	-99,57	-429,55%	0,41%	US$ 85,93 B	0,97%
CAH	25,72	-13,51	-52,54%	1,36%	US$ 35,60 B	0,60%
BIIB	11,64	1,17	10,08%	0,00%	US$ 20,68 B	17,46%

comparison of XOMAP with indexes

If you had invested (change) 2 years years ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history XOMAP dividend history

current DY: 6,34%

5-year average DY: 9,05%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	03/07/2025	15/07/2025	0,53910000
Dividends	03/04/2025	15/04/2025	0,53910000
Dividends	03/01/2025	15/01/2025	0,53910000
Dividends	03/10/2024	15/10/2024	0,53910000
Dividends	03/07/2024	15/07/2024	0,53910000
Dividends	03/04/2024	15/04/2024	0,53910000
Dividends	03/01/2024	16/01/2024	0,53910000
Dividends	05/10/2023	16/10/2023	0,53910000
Dividends	03/07/2023	17/07/2023	0,53910000
Dividends	04/04/2023	17/04/2023	0,53910000
Dividends	04/01/2023	17/01/2023	0,53910000
Dividends	03/10/2022	17/10/2022	0,53910000
Dividends	01/07/2022	15/07/2022	0,53910000
Dividends	01/04/2022	15/04/2022	0,53910000
Dividends	04/01/2022	18/01/2022	0,52340000
Dividends	01/10/2021	15/10/2021	0,53910000
Dividends	02/07/2021	15/07/2021	0,53910000
Dividends	02/04/2021	15/04/2021	0,71880000

ABOUT THE COMPANY XOMA

XOMA Corporation

Average user rating I10

4.0 (3 people)

Estados Unidos

44 years

Foundation: 1981

1986

Year of debut on the stock exchange - 39 years

10

Employees

The Company XOMA Corporation (Estados Unidos), is listed on Nasdaq with a market value of $ 300,39 Milhões, having a net worth of $ 84,81 Milhões.

With a total of 10 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 21,61 Milhões, which generated a loss in the amount of $ -29,96 Milhões.

As for its main indicators, the Company has a P/E ratio of -10,03, a P/BV ratio of 3,54 and in the last 12 months the dividend yield of XOMAP was at 6,34%.

The Company is traded internationally through the ticker XOMAP.

Market value

US$ 300,39 Milhões

Net worth

US$ 84,81 Milhões

US$ 84.810.000,00

Assets

US$ 223,34 Milhões

US$ 223.340.000,00

Total Number of Shares

11,78 Milhões

11.780.000

Average Daily Trading Volume

US$ 1,30 Thousand

US$ 1.296,28

Sector

Health Care

Industry

Biotechnology

XOMAP

XOMAP revenue and profits

XOMAP results

DRAG THE FRAME TO SEE MORE DATA

XOMAP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 719,80 41,62% (12M)

P/L

23,18

0,41%

ROE

-429,55%

P/VP

-99,57

CAH - Cardinal Health

US$ 152,47 38,27% (12M)

P/L

25,72

1,36%

ROE

-52,54%

P/VP

-13,51

JNJ - Johnson & Johnson

US$ 178,50 11,92% (12M)

P/L

16,71

2,83%

ROE

32,50%

P/VP

5,43

MRK - Merck & Co.

US$ 85,15 --22,88% (12M)

P/L

11,91

3,81%

ROE

36,03%

P/VP

4,29

ABBV - AbbVie

US$ 220,22 17,56% (12M)

P/L

100,08

3,04%

ROE

-2.726,81%

P/VP

-2.728,87

PFE - Pfizer

US$ 24,86 --9,07% (12M)

P/L

15,38

6,87%

ROE

10,33%

P/VP

1,59

AZN - AstraZeneca

US$ 81,10 4,90% (12M)

P/L

27,19

2,53%

ROE

20,79%

P/VP

5,65

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 719,80 41,62% (12 M)

P/L

23,18

0,41%

ROE

-429,55%

P/VP

-99,57

CAH - Cardinal Health

US$ 152,47 38,27% (12 M)

P/L

25,72

1,36%

ROE

-52,54%

P/VP

-13,51

JNJ - Johnson & Johnson

US$ 178,50 11,92% (12 M)

P/L

16,71

2,83%

ROE

32,50%

P/VP

5,43

MRK - Merck & Co.

US$ 85,15 --22,88% (12 M)

P/L

11,91

3,81%

ROE

36,03%

P/VP

4,29

ABBV - AbbVie

US$ 220,22 17,56% (12 M)

P/L

100,08

3,04%

ROE

-2.726,81%

P/VP

-2.728,87

PFE - Pfizer

US$ 24,86 --9,07% (12 M)

P/L

15,38

6,87%

ROE

10,33%

P/VP

1,59

AZN - AstraZeneca

US$ 81,10 4,90% (12 M)

P/L

27,19

2,53%

ROE

20,79%

P/VP

5,65

Common Questions

What is the price of XOMA (XOMAP) today?

The price of XOMA (XOMAP) today is R$ 143,11, with a variation of 13.56% compared to the last year. The price of XOMA (XOMAP) started the year trading around R$ 0,00 and today it is at R$ 143,11. Follow the real-time price chart, the historical price of XOMA (XOMAP), and stock data from Ibovespa and international markets.

When does XOMA (XOMAP) pay dividends?

XOMA (XOMAP) distributed dividends in the last year,in the months of January, April, July e October totaling R$ 11,56. The Dividend Yield for the last 12 months is 6,34%.

XOMA (XOMAP) is it worth it?

Currently, XOMA (XOMAP) is priced at R$ 143,11, with a P/E of -10,03%, representing a deviation of -11,90% from its historical average P/E. In the last year, the stock showed a variation of 13.56% in its price and distributed R$ 11,56 in dividends, resulting in a Dividend Yield of 6,34%. The total shareholder return was 13,56%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of XOMA (XOMAP)?

Investing in stocks of XOMA (XOMAP) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of XOMA (XOMAP) yield today?

The yield of XOMA (XOMAP) was 4,50% in the last month, 13,56% in the last year and 0,00% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 11,56 in dividends, um Dividend Yield de 6,34%.

If you wanted to buy 100 stocks of XOMA (XOMAP) today, the total investment would be R$ 14.311,20, based on the current price of R$ 143,11.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 16.251,80
In 5 years: R$ 14.311,20
In 10 years: 14.311,20

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

XOMAP

XOMA Corporation

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of XOMAP

check out the fundamentals of XOMA shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

If you had invested (change) 2 years years ago, today you would have

current DY: 6,34%

5-year average DY: 9,05%

type

date with

payment date

value

ABOUT THE COMPANY XOMA

XOMA Corporation

Estados Unidos

44 years

1986

10

XOMAP results

XOMAP cash flow

evolution of assets - XOMAP

XOMAP balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80